Conference Scene: Molecular pharming: Manufacturing medicines in plants

Immunotherapy

Volumn 5, Issue 1, 2013, Pages 9-12

  Lössl, Andreas G ^a,b   Clarke, Jihong L ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NORWEGIAN INSTITUTE OF BIOECONOMY RESEARCH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; HERBACEOUS AGENT; INFLUENZA VACCINE; MONOCLONAL ANTIBODY;

CHLOROPLAST; CONFERENCE PAPER; DENGUE VIRUS; DRUG INDUSTRY; DRUG MANUFACTURE; HEPATITIS VIRUS; HUMAN; MOLECULAR FARMING; NONHUMAN; PHARMACOGNOSY; PRIORITY JOURNAL; SAFFLOWER; VIRUS LIKE AGENT;

ANTIBODIES, MONOCLONAL; BIOTECHNOLOGY; HUMANS; MOLECULAR FARMING; PLANTS, GENETICALLY MODIFIED; TECHNOLOGY, PHARMACEUTICAL; VACCINES;

EID: 84871605502     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.12.146     Document Type: Conference Paper

References (23)

1. Farid SS. Process economics of industrial monoclonal antibody manufacture. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 848(1), 8-18 (2007).
2. Pollock J, Ho SV, Farid SS. Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty. Biotechnol. Bioeng. 110(1), 206-219 (2013).
3. Shaaltiel Y, Bartfeld D, Hashmueli S et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol. J. 5, 579-590 (2007).
4. Fischer R, Schillberg S, Hellwig S, Twyman RM, Drossard J. GMP issues for recombinant plant-derived pharmaceutical proteins. Rev. Biotechnol. Adv. 30, 434-439 (2012).
5. Ma JK, Drake PMW, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Gen. 4, 794-805 (2003).
6. Clarke JL, Daniell H. Plastid biotechnology for crop production: Present status and future perspectives. Plant Mol. Biol. 76, 211-220 (2011).
7. Lössl A, Waheed MT. Chloroplast-derived vaccines against human diseases: Achievements, challenges and scopes. Plant Biotechnol. J. 9, 527-539 (2011).
8. Waheed MT, Thönes N, Müller M et al. Expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: A step towards cost effective second generation vaccines. Transgenic Res. 20, 271-282 (2011).
9. Waheed MT, Thönes N, Müller M et al. Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus (HPV)-16 L1 antigen fused with LTB as adjuvant: Transplastomic plants show pleiotropic phenotypes. Plant Biotechnol. J. 9, 651-660 (2011).
10. Waheed MT, Gottschamel J, Hassan SW, Lössl A. Plant-derived vaccines. An approach for affordable vaccines against cervical cancer. Hum. Vaccin. Immunother. 8(3), 403-406 (2012).
11. Lössl A, Bohmert K, Harloff H, Eibl C, Mühlbauer S, Koop HU. Inducible trans-activation of plastid transgenes: Expression of the R. eutropha phb operon in transplastomic tobacco. Plant Cell Physiol. 46(9), 1462-1471 (2005).
12. Nykiforuk CL, Boothe JG, Murray EW et al. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol. J. 4, 77-85 (2006).
13. Markley N, Nykiforuk C, Boothe J, Moloney M. Producing proteins using transgenic oilbody oleosin technology. BioPharm Int. 19, 34-47 (2006).
14. Boothe J, Nykiforuk C, Shen Y et al. Seed-based expression systems for plant molecular pharming. Plant Biotechnol. J. 8, 588-606 (2010).
15. Kuang-Yuh C, Yano J, Li X et al. Safflower seed-derived Des-1,2-Apo AIMilano reduces atherosclerosis in hypercholesterolemic apolipoprotein E (-/-) mice. J. Am. Coll. Cardiol. 55, A50 (2010).
16. Nykiforuk CL, Shen Y, Murray EW et al. Expression and recovery of biologically active recombinant apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnol. J. 9, 250-263 (2011).
17. Juárez P, Presa S, Espí J et al. Neutralizing antibodies against rotavirus produced in transgenically labelled purple tomatoes. Plant Biotechnol. J. 10, 341-352 (2012).
18. Sarrion-Perdigones A, Falconi EE, Zandalinas SI et al. GoldenBraid: An iterative cloning system for standardized assembly of reusable genetic modules. PLoS ONE 6(7), e21622 (2011).
19. Sainsbury F, Thuenemann EC, Lomonossoff GP. pEAQ: Versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol. J. 7, 682-693 (2009).
20. Love AJ, Chapman SN, Matic S, Noris E, Lomonossoff GP, Taliansky M. In planta production of a candidate vaccine against bovine papillomavirus type 1. Planta 236, 1305-1313 (2012).
21. Sainsbury F, Saxena P, Geisler K, Osbourn A, Lomonossoff GP. Using a virus-derived system to manipulate plant natural product biosynthetic pathways. Methods Enzymol. 517, 185-202 (2012).
22. Drake PMW, Barbi T, Sexton A et al. Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. FASEB J. 23, 3581-3589 (2009).
23. Drake PMW, Thangaraj H. Molecular farming, patents and access to medicines. Expert Rev. Vaccines 9(8), 811-819 (2010).